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Immunity declines with age (Yoshikawa, 2000). 
This may explain the age-associated increase in 
the frequency of cutaneous tumors and infec-
tions (Laube, 2004; Diffey and Langtry, 2005). 
Most studies directed at identifying defects in 
the immune system during aging have fo-
cused on circulating leukocyte populations, 
but it is not clear if the results obtained can be 
extrapolated to the behavior of leukocytes 
within tissues. Clearly, a more informative ex-
perimental system is required to define the   
nature of the age-related attenuation of cuta-
neous immunity.
The intradermal injection of recall antigens 
such as tuberculin purified protein derivative 
(PPD) or Candida albicans (Orteu et al., 1998; 
Reed et al., 2004; Vukmanovic-Stejic et al., 
2008) induces a delayed type hypersensitivity re-
action (DTH) in the skin, which has been used as 
a measure of systemic immunity in vivo (Turk, 
1980). There are distinct phases of the DTH re-
sponse. First, the presence of antigen and trauma 
to the skin induce nonspecific “danger signals,” 
that recruit and activate cells of the innate immune 
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Immunity declines during aging, however the mechanisms involved in this decline are not 
known. In this study, we show that cutaneous delayed type hypersensitivity (DTH) responses 
to recall antigens are significantly decreased in older individuals. However, this is not 
related to CC chemokine receptor 4, cutaneous lymphocyte-associated antigen, or CD11a 
expression by CD4+ T cells or their physical capacity for migration. Instead, there is defec-
tive activation of dermal blood vessels in older subject that results from decreased TNF- 
secretion by macrophages. This prevents memory T cell entry into the skin after antigen 
challenge. However, isolated cutaneous macrophages from these subjects can be induced to 
secrete TNF- after stimulation with Toll-like receptor (TLR) 1/2 or TLR 4 ligands in vitro, 
indicating that the defect is reversible. The decreased conditioning of tissue microenviron-
ments by macrophage-derived cytokines may therefore lead to defective immunosurveil-
lance by memory T cells. This may be a predisposing factor for the development of 
malignancy and infection in the skin during aging.
© 2009 Agius et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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in the skin of old subjects after injection of recall antigens.   
At 72 h after injection, young subjects had obvious clinical 
responses to tuberculin PPD, C. albicans (Candin), and VZV 
skin test antigen, whereas the clinical score for old subjects 
was significantly lower (Fig. 1, A and B; P = <0.0001). We 
next investigated whether the older subjects had a general-
ized defect in the ability to respond to antigen. To do this, 
we obtained PBMCs from young and old volunteers at the 
same time we injected the recall antigens, and then examined 
the proliferative responses of their T cells to stimulation with 
these antigens in vitro. In young individuals, good prolifer-
ative responses (>10,000 cpm) were associated with a robust 
clinical response in the skin. However, a large number of old 
individuals who failed to develop a clinical response in the 
skin had robust PBMC responses to antigen in vitro (Fig. 1 C). 
This indicates that they have defective local immune re-
sponses to secondary antigen challenge in the skin that does 
not reflect a global loss of systemic immunity.
Reduced CD3+ and CD4+ T cell infiltration during secondary 
immune responses in old subjects
Optimal secondary immune responses in the skin are depen-
dent on antigen-specific CD4+ T cells (Poulter et al., 1982). 
We next determined whether the defective clinical response 
in old subjects was associated with decreased CD4+ T cell in-
filtration after antigen challenge. Immunocytochemical stain-
ing of skin sections 3 d after challenge with C. albicans antigens 
showed that lymphocytic perivascular infiltrates in the papil-
lary and reticular dermis of young skin were larger than those 
in corresponding sections from old subjects (Fig. 2 A). Fur-
thermore, there were reduced numbers of CD3+ (Fig. 2 B) 
and CD4+ T lymphocytes (Fig. 2 C) in perivascular infiltrates 
in old skin sections at all time points studied (Fig. 2 D), indi-
cating that the results obtained were not caused by a shift in 
the kinetics of the response in old individuals. In addition, 
old and young subjects have similar proportions of PPD and 
C. albicans-specific CD4+T lymphocytes in the blood; how-
ever, the former had significantly lower proportions of   
Ag-specific CD4+ T cells in the skin (Fig. 2 E). This indicates 
that the inability to mount a clinical response to recall antigen 
challenge in older individuals is associated with decreased   
cutaneous antigen-specific CD4+ T cell infiltration.
Expression of skin homing receptors and capacity of CD4+  
T cells to migrate is not reduced during aging
As circulating Ag-specific cells are not decreased in the old 
subjects, we hypothesized that these cells might be impaired in 
their capacity to migrate into the skin after antigen injection. 
We therefore investigated the expression of cutaneous lym-
phocyte-associated antigen (CLA; Fuhlbrigge et al., 1997), CC 
chemokine receptor 4 (CCR4), a chemokine receptor found 
on skin homing T cells (Imai et al., 1997), and CD11a, which 
is essential for firm adhesion to endothelium via interaction 
with  the  2-integrin  intercellular  adhesion  molecule-1 
(ICAM-1; von Andrian and Mackay, 2000), on CD4+ T cells 
from old and young individuals. We found that the decreased 
system (Matzinger, 2002). This is crucial for conditioning of   
the inflammatory environment to enable the recruitment of   
antigen-specific T cells from the blood (Kupper and Fuhlbrigge, 
2004). Coincident with this, antigen is sequestered and processed 
by Langerhans and dendritic cells that migrate via the lymphatics 
to the lymph node, where they present antigen to and activate 
memory T cells populations (Jakob et al., 1998; Saeki et al., 
1999). These memory T cells then migrate via the blood stream 
to the site of the antigenic insult, where they traverse activated 
endothelium in tissue that had been conditioned by “innate sig-
nals” and amplify the response (Campbell and Butcher, 2002; 
Greening et al., 2003; Kupper and Fuhlbrigge, 2004). Nonim-
mune individuals do not mount a DTH response to antigen, de-
spite the fact that equal levels of antigen and trauma to the skin 
are present (Orteu et al., 1998; Reed et al., 2004; Vukmanovic-
Stejic et al., 2008). This highlights the necessity of memory 
T cell recruitment for the amplification step of this response 
to take place (Vukmanovic-Stejic et al., 2008). Antigen-specific 
and -nonspecific events therefore have to be induced and coor-
dinated to enable a DTH response to occur (Turk, 1980).
We previously characterized the kinetics of memory and 
regulatory T cell infiltration into the skin of healthy humans 
during DTH responses (Orteu et al., 1998; Reed et al., 2004; 
Vukmanovic-Stejic et al., 2008). To do this, we performed 
histological analysis of infiltrating cells in biopsies taken from 
the site of the response at different times after antigen injection 
(Orteu et al., 1998; Reed et al., 2004; Vukmanovic-Stejic et al., 
2008). We also induced skin suction blisters at the site of anti-
gen challenge that allowed us to harvest live infiltrating leuko-
cytes  for  phenotypic  and  functional  analyses  (Reed  et  al., 
2004; Vukmanovic-Stejic et al., 2008). Using these techniques, 
we now show that old humans have decreased DTH responses 
to bacterial (PPD), fungal (C. albicans), or viral (varicella-
zoster virus [VZV]) antigens. This was caused by decreased 
endothelial activation by macrophage-secreted TNF- that 
prevents  the  recruitment  of  antigen-specific  CD4+  T  cells 
from the blood. Furthermore, this defect is caused by a lack of 
macrophage activation in the skin and not a defect in the mac-
rophages per se, as these cells could be induced to synthesize 
TNF- after stimulation with TLR ligands in vitro. We sug-
gest that decreased TNF- secretion occurs in part through 
inhibition by CD4+Foxp3+ regulatory T cells, which can di-
rectly inhibit TNF- secretion by macrophages (Taams et al., 
2005; Tiemessen et al., 2007), and these cells were signifi-
cantly increased in the skin of old subjects. Collectively, our 
results suggest that strategies that boost the function of macro-
phages or other components of the cutaneous innate immune 
system may promote the infiltration of and immunosurveil-
lance by T cells from the blood. This may be a way to reduce 
the risk of infections and malignancy during aging.
RESULTS
Decreased cutaneous DTH responses in healthy  
old individuals
We first examined whether the clinical (erythema and indu-
ration) or cellular response to antigen challenge was reduced JEM VOL. 206, August 31, 2009 
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(Fig. 3 D). Furthermore, this migration was blocked by 
the addition of anti–ICAM-1 and anti–VCAM-1 antibodies 
(Fig. 3 E), supporting the direct requirement for these mole-
cules in the migration process (McHale et al., 1999). Hence, 
the defect in accumulation of antigen-specific CD4+ T cells 
in the skin of old donors after antigen challenge was not 
caused by alterations in the physical migratory capacity of the 
T cells themselves.
Reduced expression of adhesion molecules by dermal 
endothelium during a DTH response in old subjects
The activation of dermal blood vessel endothelial cells in-
duces expression of E-selectin, ICAM-1, and VCAM-1, the 
ligands to CLA, CD11a, and VLA-4 on T cells (Berg et al., 
migration of T cells into the skin after antigen challenge in old 
subjects was not caused by decreased expression of key cell 
surface molecules on circulating CD4+ T cells (Fig. S1).
We next used time-lapse phase-contrast microscopy to 
investigate the physical capacity of T cells from old subjects 
to migrate across primary human dermal microvascular endo-
thelial cells (HDMECs) in vitro. The HDMECs were preac-
tivated with TNF- and IFN- to stimulate E-selectin, 
ICAM-1, and vascular cell adhesion molecule-1 (VCAM-1) 
expression (Swerlick et al., 1992). Adhesion molecule ex-
pression and CD4 cell migration was minimal when using 
resting endothelium (Fig. 3, A–C). However, CD4+ T cells 
from the blood of old subjects migrated more efficiently than 
those from the young group across activated endothelium 
Figure 1.  Cutaneous DTH responses are reduced in old individuals. Young and old volunteers were injected intradermally with 0.1 ml of 10 U/ml 
tuberculin PPD (n = 20 young, 32 old), 0.02 ml Candin skin antigen test (n = 40 young, 34 old), or 0.02 ml VZV skin test antigen (n = 11 young, 15 old).  
(A) A photograph of the injection site 3 d after PPD injection. Bar, 1 cm. (B) Induration diameter, erythema index, and palpability of the lesion were 
assessed and graded at day 3, and a clinical score was assigned based on these parameters (***, P < 0.0001; **, P < 0.001; Mann-Whitney test). (C) Freshly 
isolated PBMCs were stimulated with PPD (n = 18 young, 28 old), C. albicans (n = 23 young, 19 old), or VZV (n = 7 young, 10 old) in vitro for 5–6 d. 
Proliferation was assessed by [3H]thymidine incorporation and plotted against corresponding clinical score. Each symbol represents the result from 
one individual.1932 RESTRICTED IMMUNOSURVEILLANCE BY CD4+ T CELLS IN AGING SKIN | Agius et al.
the dermal endothelial vessels. There was a significant re-
duction in the proportion of capillary loops that expressed 
E-selectin in old skin at 24 h (not depicted) and at day 3 
(Mann-Whitney test; P = 0.008; Fig. 4, A and B). Further-
more, dermal endothelial cells from the site of injection in 
old subjects also showed significantly reduced VCAM-1 ex-
pression compared with young controls (P = 0.016; Fig. 4,   
C and D). The expression of ICAM-1 was found on all dermal 
capillary loops throughout skin sections from old subjects, 
1991; Alon et al., 1995; Berlin et al., 1995). We therefore in-
vestigated whether the lack of T cell infiltration into the skin 
in these individuals was caused by defective endothelial cell 
activation. We found that the number of capillary loops, 
identified by their expression of CD31 (Newman, 1997), was 
not decreased in old compared with young subjects (unpub-
lished data). Skin biopsies from day 3 post–C. albicans skin 
test injections from young and old skin were stained for these 
adhesion molecules in conjunction with CD31 to highlight 
Figure 2.  Cellular infiltrate at the site of cutaneous DTH response is reduced in the old. Young and old volunteers were injected with 0.02 ml 
Candin skin antigen test and 5-mm punch biopsies were performed on days 1, 3, or 7 after injection. (A) Hematoxylin and eosin staining of skin sections 
from one young and one old individual on day 3 after Candin injection showing perivascular infiltrates (black arrow). The results are representative stains 
of three young and three old subjects that were tested. Day 3 biopsies were stained for CD3 (B) and CD4 (C) using an indirect immunoperoxidase immuno-
histochemical technique. The results shown are representative of five young and four old subjects and the quantification of this data are included in D.  
(D) The number of CD3+ and CD4+ T cells within perivascular infiltrates was determined by counting the number of positive cells within the five largest 
perivascular infiltrates per skin section. Mean ± SEM of 4–7 individuals per time point is shown (*, P = 0.01; **, P = 0.007; Mann-Whitney test; n = 20 old, 
22 young with 4–7 volunteers per time point). (E) The percentage IFN-–producing antigen specific CD4+ T lymphocytes in old blisters is significantly 
reduced compared with young (n = 10 young, 5 old; **, P = 0.001, for PPD specific cells and n = 6 young, 10 old; *, P = 0.04 for C. albicans). Each symbol 
represents the result of a single subject. Horizontal bars represent the median. Bars, 100 µm.JEM VOL. 206, August 31, 2009 
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but the intensity of staining was reduced in skin sections from 
all six old donors compared with five young donors as as-
sessed independently by two investigators. The defective 
accumulation of T cells during the response to recall anti-
gen in the skin in old donors is therefore linked to reduced 
expression of adhesion molecules on the endothelium of 
dermal vessels.
To determine if the reduction in endothelial adhesion 
molecule expression in the skin of old donors was caused by 
Figure 3.  CD4+ T cells from old volunteers show adequate ability 
to migrate across the dermal endothelial monolayer in vitro.  
(A) Photomicrographs immunostaining of HDMEC monolayer for VCAM-1 
and ICAM-1 (green) on unactivated (top) and activated (bottom) endothe-
lium. Endothelial monolayers were activated with TNF- (110,000 U/ml) 
and IFN- (100 U/ml) for 24 h before addition of T cells. Bar,10 µm.  
(B) Graph showing ICAM-1 and VCAM-1 up-regulation upon HDMEC 
activation. Results were expressed as mean ± SEM of triplicate wells.  
(C) Bar graph showing increased total CD4+ T cell migration across stimu-
lated HDMEC compared with unstimulated endothelium. To evaluate the 
level of migration, CD4+ T cells isolated from young and old volunteers 
were plated onto confluent dermal endothelial monolayers for 4 h at 37°C 
and 5% CO2 (n = 3 young, 3 old). (D) The percentage total migration for 
old versus young CD4+ T cells across stimulated endothelium was signifi-
cantly different (Mann Whitney *, P = 0.02; n = 4 young, 4 old). (E) Graph 
showing effect of adding blocking antibodies to ICAM-1, VCAM-1 and  
E-selectin on total CD4+ lymphocyte migration (Paired t test *P = 0.04). 
Results were expressed as mean ± SEM of three separate experiments.
Figure 4.  Dermal endothelium in old individuals shows reduced 
expression of adhesion molecules. Histological sections (6 µm) from 
skin injected with C. albicans (n = 5 young, 6 old) at day 3 after injec-
tion were stained with antibody to CD31 to highlight dermal capillary 
loops and endothelial adhesion molecules E-selectin VCAM-1 and 
ICAM-1. (A) Double immunofluorescence staining of representative bi-
opsies for one young and one old individual showing CD31 (green) and 
E-selectin (red). Capillary loops expressing adhesion molecules appear 
yellow (merge). This staining was repeated on biopsies of skin 3 d after 
C. albicans injection in five different young and five different old sub-
jects. The collective results are shown in B. The graph shows percentage 
of capillary loops expressing E-selectin and the horizontal line indicates 
the mean (**, P = 0.008, young vs. old, Mann-Whitney test). (C) VCAM-1 
(red) and CD31 (green) expression by skin biopsies taken 3 d after  
C. albicans injection. Representative staining of one young and one old 
subject is shown. These experiments were performed on four young and 
five old subjects, and the collective results are shown in D. Graph shows 
the percentage of capillary loops expressing VCAM-1; each symbol rep-
resents an individual, and lines indicate the mean (*, P = 0.015, young 
vs. old). (E) ICAM-1 (red) and CD31 (green) immunofluorescence staining 
of skin biopsies from one representative young and one representative 
old individual 3 d after C. albicans injection. These experiments are rep-
resentative results of staining that was performed in five young and five 
old subjects. Bars, 100 µm.1934 RESTRICTED IMMUNOSURVEILLANCE BY CD4+ T CELLS IN AGING SKIN | Agius et al.
IFN-, and IL-6 were significantly lower in old compared 
with young subjects (P = 0.014 for TNF-; P = 0.013 for 
IFN-; and P = 0.031 for IL-6; Fig. 6 A). In contrast, the 
concentration of IL-10 was not different between both 
groups (Fig. 6 A). IL-2, IL-7, and IL-15 were also assessed, 
but were found to be undetectable in blister fluid from young 
and old subjects (unpublished data). The reduction in endo-
thelial adhesion molecule expression in old subjects was 
therefore related to decreased induction of proinflammatory 
cytokines in the skin after antigen challenge.
Previous studies have shown that skin macrophages are 
mainly responsible for TNF- and IL-6 secretion after cuta-
neous challenge with recall antigens, whereas IFN- is se-
creted mainly by T lymphocytes (Chu et al., 1992). Using 
CD163 as a marker for macrophages and CD11c as a marker 
for dendritic cells (Zaba et al., 2007), we found similar num-
bers of both populations in skin of young and old subjects 
after injection with C. albicans antigens (Fig. 6 B and not 
depicted). This was confirmed when macrophages were 
identified by CD68 and CD14 (unpublished data). There was 
extensive TNF- expression in CD163+ macrophages from 
young donors after 24 h and at 3 d after antigen challenge 
(Fig. 6 C). In contrast, TNF- was undetectable in these cells 
from old subjects at both time points (Fig. 6 C). Further-
more, TNF- was not detectable in CD11c+ cells and kera-
tinocytes (Fig. S2 and not depicted). These results were 
confirmed by immunohistochemical staining for TNF- 
(Fig. S2). We therefore extend previous observations that 
macrophages are the main source of TNF- after cutaneous 
antigen challenge and show that this synthesis is defective in 
old individuals (Chu et al., 1992).
Dermal macrophages from old individuals can be induced  
to secrete TNF- in vitro
The lack of TNF- secretion by macrophages in old subjects 
could have been caused by lack of activating signals for these 
cells in the aged skin microenvironment after antigen injec-
tion, or a generalized defect in macrophage activation in old 
individuals. To clarify this, we investigated the capacity of 
macrophages that were isolated from the skin of old and 
young subjects 48 h after injection with C. albicans, to secrete 
TNF- upon challenge with the TLR-1/2 ligand PAM3CKS4 
or a TLR-4 ligand LPS in vitro. Peripheral blood monocytes 
were examined in parallel. Peripheral blood CD14+ mono-
cytes and cutaneous macrophages from both young and old 
donors  secreted  significantly  more  TNF-  in  response  to 
LPS and PAM3CKS4 compared with unstimulated controls 
in vitro (Fig. 7, A and B). However, in contrast to the low 
TNF- production of old macrophages in vivo, cutaneous 
macrophages from old and young subjects secreted similar 
levels of TNF- in response to LPS and PAM3CKS4 stimu-
lation in vitro (Fig. 7, A and B). To determine whether the 
activation threshold of monocytes from old volunteers was 
higher than that in the young, we stimulated peripheral blood 
CD14+ monocytes with both high and low doses of LPS. No 
difference was observed in the TNF- production between 
an intrinsic defect in the endothelium, we obtained skin bi-
opsies from normal young and old volunteers (n = 3 young, 
3 old) and incubated the tissue with medium containing 
TNF- and IFN- or medium alone for 16 h (Fig. 5). We 
found that there was an increase in the intensity of E-selectin, 
ICAM-1, and VCAM-1 on the endothelium in the presence 
of TNF- and IFN- in all the old and young subjects (as as-
sessed independently by two investigators). A representative 
VCAM-1 staining profile is shown in Fig. 5. Similar results 
were obtained for E-selectin and ICAM-1 (not depicted). 
This suggests that old endothelium is able to express adhesion 
molecules in the presence of appropriate cytokines and is 
therefore not inherently defective.
Dermal CD163+ macrophages do not secrete TNF-  
in old subjects
To investigate whether there was a reduction in cytokines 
that activate endothelium, including TNF- (McHale et al., 
1999), IFN-, and IL-6 (Swerlick et al., 1992; Kluger et al., 
1997; Wung et al., 2005) in the skin of old individuals, we 
measured the levels of these mediators in the fluid from skin 
blisters that were induced after 48 h at the site of C. albicans 
injection (n = 10 old, 6 young). The concentrations of TNF-, 
Figure 5.  Old endothelium is not defective and can up-regulate 
adhesion molecules in vitro. Young and old normal skin explants were 
cultured in RPMI + 10% human serum or in RPMI + 10% human serum 
supplemented with TNF- (110,000 U/ml) and IFN- (100 U/ml) for 16 h 
at 37°C and 5% CO2. Histological sections from skin explants were stained 
with antibodies to CD31 and E-selectin, ICAM-1, and VCAM-1. The results 
shown represent one young (A and B) and one old (C and D) subject 
showing VCAM-1 (red) and CD31 (green) staining. These experiments were 
performed in a total of three different young and three different old sub-
jects that showed similar results. Bars, 100 µm.JEM VOL. 206, August 31, 2009 
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old  subjects  was  associated  with  increased  proportions  of 
these cells in the skin. In a previous study, we showed that 
cutaneous CD4+Foxp3+ T cells expressed typical phenotypic 
and functional characteristics of regulatory cells (Vukmanovic-
Stejic et al., 2008). There was a significant increase in the 
proportion of these cells in the skin of old subjects compared 
with the young group either before or after injection of anti-
gen (Fig. 8, A and B). In addition, T reg cells from young and 
old subjects suppress responses to C. albicans antigens equally 
(Fig. S4), which is in line with previous studies using other 
antigens (Vukmanovic-Stejic et al., 2006). Collectively, this 
these cells from both groups (Fig. S3). Thus, once removed 
from the skin environment macrophages can synthesize 
TNF-, suggesting that the cutaneous immune defect in old 
individuals may be reversible.
Increased representation of CD4+Foxp3+ regulatory T (T reg) 
cells in the skin of old humans
Previous studies have shown that CD4+Foxp3+ T reg cells 
can inhibit TNF- secretion by macrophages (Taams et al., 
2005; Tiemessen et al., 2007). We therefore investigated 
whether the decreased macrophage production of TNF- in 
Figure 6.  Levels of TNF- are reduced in blister fluid and in CD163+ macrophages in old skin. (A) Skin suction blisters were raised over the site 
of C. albicans antigen injection at day 3. Levels of TNF-, IFN-, IL-10 and IL-6 were measured in the blister fluid using cytometric bead arrays. The results 
shown are the mean and SEM of 6 young and 10 old subjects for each cytokine tested. A significant reduction in the level of TNF-, IFN-, and IL-6 was 
noted in the old group compared with the young group (Mann-Whitney test; *, P = 0.01 for TNF- and IFN-; *, P = 0.03 for IL-6). The number of CD163+ 
cells within the dermis was determined by indirect immunoperoxidase staining of 6-µm tissue sections. (B, left) Representative staining of one young and one 
old subject 3 d after C. albicans injection. We investigated a total of five young and six old volunteers, and the collective results are shown (B, right). We also 
investigated the presence of CD163+ macrophages at different times after C. albicans injection (B, right). Graph shows mean number of CD163+ macrophages 
before injection (n = 5 young, 5 old), day 1 (n = 5 young, 7 old), and day 3 after injection (n = 5 young, 6 old). The data represent the mean ± SEM. Bar, 100 µm. 
Double immunofluorescence staining of TNF– (green) and CD163 (red) in skin biopsies 3 d after C. albicans injection. Results shown are representative of 
one young and one old subject (C, left). These experiments were performed in three young and three old subjects and the collective results showing the mean 
and SEM of the percentage of CD163+ macrophages producing TNF- per perivascular infiltrate are shown in (C, right). Bar, 100 µm.1936 RESTRICTED IMMUNOSURVEILLANCE BY CD4+ T CELLS IN AGING SKIN | Agius et al.
there may be a generalized defect in skin reactivity during 
aging. This may be the biological basis for the increased sus-
ceptibility of old subjects to both cutaneous malignancy and 
infections (Laube, 2004; Diffey and Langtry, 2005). An un-
expected observation was that the defect in the response to 
cutaneous antigenic challenge was not in the memory T cell 
compartment, but in the innate conditioning of the skin after 
antigen stimulation.
Although T cell numbers are decreased after antigen chal-
lenge, macrophages identified by CD163 (this study) or 
CD68 and CD14 (unpublished data) are present in equal 
numbers in young and old skin. This is likely because of the 
different trafficking requirements of different leukocytes. It 
has been shown that DC-SIGN–ICAM-2 interactions medi-
ate dendritic cell trafficking (Geijtenbeek et al., 2000), and 
DC-SIGN is also strongly expressed on CD163+ macro-
phages in both normal and inflamed skin (Zaba et al., 2007). 
We have also found high levels of DC-SIGN expression by 
activated peripheral blood monocytes (unpublished data). 
data suggests that the overrepresentation of T reg cells in the 
skin may explain, in part, the decreased TNF- secretion by 
cutaneous macrophages in old humans.
DISCUSSION
The cutaneous DTH response to antigen is widely consid-
ered to be a manifestation of memory T cell responsiveness in 
vivo. The central observation of this study is that this re-
sponse to challenge by a panel of recall antigens was defective 
in older humans. In addition, the incidence of positive con-
tact hypersensitivity reactions is also decreased in the elderly 
(Piaserico et al., 2004; Balato et al., 2008). This suggests that 
Figure 7.  Macrophages isolated from the skin of old donors 
secrete TNF- in response to TLR signals in vitro. Cells removed from 
skin suction blisters 48 h after C. albicans injection were stimulated with 
LPS (100 ng/ml; Sigma-Aldrich), Pam3CSK4 (1 µg/ml), or medium as a 
control for 4 h in the presence of GolgiStop, and then stained for CD14, 
CD163, and TNF–. PBMCs were stimulated in parallel. (A) Graph shows 
percentage of TNF-–secreting CD14+ cells after in vitro stimulation of 
PBMCs with medium alone or LPS (n = 11 young, 11 old) and Pam3CSK4 
(n = 6 young, 7 old). Each symbol represents the results from one individual. 
The percentage of CD14+ cells producing TNF- after in vitro stimulation of 
blister cells with LPS (n = 6 young, 7 old) and Pam3CSK4 (n = 3 young, 4 for 
old). (B) Each symbol represents the results from one individual.
Figure 8.  Numbers of CD4+Foxp3+ T reg cells are increased in the 
skin of old subjects. (A) Double immunofluorescence staining of repre-
sentative biopsies from young and old normal skin; CD4+ (green) and 
Foxp3+ (red) cells in a perivascular lymphocytic infiltrate. CD4+Foxp3+ cells 
are indicated by a white arrow. Bar, 100 µm. (B) Percentage of CD4+ cells 
expressing Foxp3 per perivascular infiltrate counted. The five largest peri-
vascular infiltrates present in the upper and mid-dermis were selected for 
analysis for each subject. Each symbol represents an average of five peri-
vascular infiltrates counted for each individual (n = 5–7 subjects per time 
point, line indicates the mean).JEM VOL. 206, August 31, 2009 
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confirmed  in  other  studies  (van  Duin  and  Shaw,  2007). 
However, we found that both peripheral blood monocytes 
and isolated cutaneous macrophages from donors of both age 
groups synthesized similar levels of TNF- after TLR-1/2 
and TLR-4 stimulation in vitro. We therefore conclude that 
cutaneous macrophages in old humans are not inherently de-
fective in terms of TNF- synthesis, but do not rule out the 
possibility that other functions in these cells may be altered 
during aging. This is currently under investigation.
In addition to the need for TLR signaling for macro-
phage activation, these cells must also interact with cytokines 
such as IFN- to become fully functional. Previous studies 
have shown that IFN- is mainly secreted by T cells during 
DTH responses (Chu et al., 1992). The lack of IFN- in the 
skin in our studies may reflect the decreased infiltration of 
T cells into the site of antigen challenge. Activation by IFN- 
leads to the expression of several genes that regulate macro-
phage biology, including expression of MHC class II genes 
(Celada and Maki, 1991; Goñalons et al., 1998; Cullell-Young 
et al., 2001), which are crucial for antigen presentation to 
T lymphocytes. It is possible that the lack of T cell signals 
such as IFN- early in the DTH response in old subjects may 
prevent the cascade of events required for amplification of 
the response.
An alternative possibility is that macrophages in the skin 
of old individuals may be inhibited functionally in situ. It 
has been shown that human CD4+Foxp3+ T reg cells are 
potent inhibitors of macrophage activation and TNF- 
secretion by these cells (Taams et al., 2005; Tiemessen et al., 
2007). In addition, in a previous study we showed that 
there is a significant increase in functional circulating T reg 
cells in old individuals (Vukmanovic-Stejic et al., 2006), 
which is in agreement with the observation that functional 
T reg cells accumulate in tissues of aged mice (Lages et al., 
2008). We now show that there are significantly higher 
proportions of CD4+Foxp3+ T cells in the skin of old vol-
unteers either before or 7 d after injection of C. albicans 
antigens. Although circumstantial, this suggests that the ac-
cumulation of T reg cells in the skin may be one possible 
mechanism for the observed decrease of TNF- secretion 
by cutaneous macrophages in old individuals. This is cur-
rently under investigation.
With increasing age, cellular debris is not cleared opti-
mally and accumulates within blood vessels and tissues, trig-
gering nonspecific immune responses (for review see Richards 
et al., 2007). This may manifest as atherosclerosis, the accu-
mulation of amyloid proteins leading to Alzheimer’s disease, 
lipofuscin pigments leading to age-related macular degenera-
tion, and crystal arthritis that results from the defective re-
moval  of  uric  acid  (Richards  et  al.,  2007).  The  reduced 
activation of macrophages in the skin and possibly other tis-
sues may reduce the occurrence of chronic nonspecific   
inflammatory responses in old individuals. However, this re-
duced activation can also lead to decreased tissue-specific   
immunosurveillance by memory T cells. For successful   
aging to occur, it is therefore crucial to reduce nonspecific 
ICAM-2 is constitutively expressed on endothelial cells and, 
in contrast to E-selectin, VCAM-1, and ICAM-1, its expres-
sion is not dependent on the presence of TNF- (Silverman 
et al., 2001). Activated monocytes may therefore enter the 
skin by alternative pathways of transmigration through the 
endothelium compared with memory T cells. Furthermore, 
significant numbers of CD163+ macrophages are present in 
the skin of both young and old subjects, even without injec-
tion of antigen; therefore, the recruitment of circulating 
myeloid cells at the very early stages of the response may not 
be a limiting step in DTH responses of old humans.
The dominant role of TNF- in regulating leukocyte 
migration via the activation of endothelial cells is supported 
by studies using models of contact hypersensitivity (McHale 
et al., 1999). Furthermore, it was found that anti–TNF- 
therapy in humans decreases the expression of the adhesion 
molecules E-selectin, ICAM-1, and VCAM-1 in various as-
says, leading to reduced trafficking of leukocytes (Paleolog 
et al., 1998). This decreased endothelial activation is associated 
with an increase in the frequency of skin and soft tissue infec-
tions  in  anti–TNF-–treated  rheumatoid  arthritis  patients 
compared with those receiving traditional disease-modifying 
antirheumatic drugs (Dixon et al., 2006).
The need for appropriate leukocyte migration for immuno-
surveillance and the prevention of disease is further under-
scored by the clinical use of anti-41 integrin mAb that 
binds to VLA-4, the main homing molecule involved in lym-
phocyte migration to inflamed brain in rodent models of 
multiple sclerosis (Engelhardt et al., 1995). A mAb to this 
molecule reduced the inflammatory infiltrate in brain tissue 
and blocked clinical paralysis in various animal models of 
multiple sclerosis (Yednock et al., 1992; Theien et al., 2003; 
Deloire  et  al.,  2004).  However,  the  use  of  Natalizumab, 
which is a humanized mAb to 41 integrin, for treatment 
of multiple sclerosis led to the development of severe oppor-
tunistic brain infections (Steinman, 2005). Thus, inhibiting 
leukocyte migration in humans can lead to severe pathologi-
cal consequences. The defect in macrophage triggering to se-
crete TNF- in the skin raises the question of whether there 
is a defect in endothelial activation during immune responses 
in other organs during aging, as the potential decrease in   
T cell immunosurveillance may contribute to the reported 
increase in susceptibility of old individuals to a wide range 
of infections (Nicholson et al., 1997; Yoshikawa, 2000; 
Schmader, 2001).
An important unanswered question is why macrophages 
in the old skin are not triggered to secrete TNF-. Previous 
studies have shown that there is an age associated defect in 
human TLR1 and 2 function that results in a significant de-
fect in TNF- secretion after ligation of these receptors (van 
Duin et al., 2007). Because C. albicans activates TLR1 and 2, 
this may explain the cutaneous defect in macrophage-derived 
TNF- that we have observed. It has also been shown that 
there is a defect in TLR4 function and expression and func-
tion during aging (Renshaw et al., 2002; Krabbe et al., 2004; 
van den Biggelaar et al., 2004), although this has not been 1938 RESTRICTED IMMUNOSURVEILLANCE BY CD4+ T CELLS IN AGING SKIN | Agius et al.
Immunofluorescence. 6-µm skin sections were blocked with Dako non-
serum protein block for 20 min. Primary antibodies E-selectin, ICAM-1, 
VCAM-1 were incubated for 1 h at room temperature and amplified with 
the appropriate secondary antibody: goat anti–mouse IgG1 conjugated with 
Alexa Fluor 546. For colocalization with CD31, sections were then costained 
with anti–human CD31FITC. For CD4 and Foxp3 staining, primary anti-
bodies (biotin anti–human Foxp3, mouse anti–human CD4) were incubated 
overnight at 4°C, followed by strepCy3 and anti–mouse IgG1 conjugated 
with Alexa Fluor 488. Slides were then washed twice in PBS and mounted 
with Vectashield containing DAPI (Vector laboratory). Images were acquired 
using appropriate filters of a Leica DMLB microscope with Leica N PLAN 
20×/0.40 objective and a Cool SNAP-Pro cf Monochrome Media Cyber-
netics camera, controlled by Image-Pro PLUS 6.2 software. When counting 
the numbers of cells in perivascular infiltrates, at least five largest perivascular 
infiltrates present in the upper and mid-dermis were selected for analysis 
(Vukmanovic-Stejic et al., 2008). Cell numbers were expressed as the mean 
absolute cell number counted within the frame. For double staining, skin 
sections from day 3 C. albicans–stimulated skin were blocked in 10% normal 
goat serum (Vector Laboratories) for 30 min. Primary antibody CD163 was 
incubated overnight at 4°C and amplified with the following: goat anti–
mouse IgG1 conjugated with Alexa Fluor 568, followed by overnight in-
cubation with directly conjugated TNF- FITC and amplified with goat 
anti-FITC Alexa Fluor 488. Images were acquired using appropriate filters of 
an Axioplan 2I microscope (Carl Zeiss, Inc.) with Plan Apochromat 20 × 0.7 
numerical aperture lens and a Hamamatsu orca ER-cooled charge-coupled 
device camera, controlled by METAVUE software (Universal Imaging).
PBMC preparation and proliferation experiments. Heparinized blood 
was collected from young and old volunteers at the time of blister aspiration or 
as specified. PBMCs were prepared by density centrifugation on Ficoll-Paque 
(GE Healthcare) and resuspended in complete medium. For migration experi-
ments, CD4 T cells were isolated by positive selection using CD4 microbeads 
according to the manufacturer’s instructions (Miltenyi Biotec). For measure-
ment of cellular proliferation by [3H]thymidine incorporation, PBMCs were 
added to 96-well round-bottomed tissue culture plates (Falcon; BD) at a con-
centration of 105 cells/well. The cells were incubated at 37°C in a humidified 
5% CO2 atmosphere for 5–6 d (5 d for PPD antigen, 6 d for C. albicans and 
VZV antigens) before adding [3H]thymidine (GE Healthcare). The mean of 
triplicate wells was calculated and used for the purpose of data analysis.
T reg cell suppression assays. CD4+ T cell subsets (CD4+CD25 and 
CD4+CD25+) were isolated using the CD4 isolation kit and CD25 microbeads 
according to the manufacturer’s instructions (Miltenyi Biotec; Vukmanovic-
Stejic et al., 2006). For suppression assays, 5 × 104 CD4+CD25 T cells were 
stimulated with C. albicans antigens and irradiated (5,000 rad) autologous 
PBMC as APC (5 × 104 cells per well) in 96-well round-bottom plates 
(Nunc). CD4+CD25+ T cells were added at responder/suppressor ratios   
of 1:0, 1:0.1, 1:0.5, and 1:1. Cells were cultured in RPMI 1640 medium 
(Invitrogen), supplemented with 1% penicillin/streptomycin, 1% l-gluta-
mine, and 10% human AB serum (all from Sigma-Aldrich), for 6 d with 
[3H]thymidine added at 1 µCi/well for the last 18 h of culture. Proliferative 
responses are expressed as percentage of proliferation in comparison to the 
proliferation of CD4+CD25 subset alone.
Flow cytometric analysis. Four-parameter analysis of blister and blood   
T cell phenotype was performed on a FACSCalibur (BD). PBMCs were 
stained with antibodies to CD3 (Dako), CD4, CLA, CCR4, and CD11a (all 
from BD). Appropriate isotype controls were used. For the detection of an-
tigen-specific cells, PBMCs (106) or blister cells were stimulated with PPD 
at a final concentration of 10 µg/ml or C. albicans antigen at a final concen-
tration of 40 µg/ml for 15 h at 37°C in a humidified 5% CO2 atmosphere. 
Brefeldin A (Sigma-Aldrich) was added at a final concentration of 5 µg/ml 
after 2 h of incubation. Unstimulated controls were also included. The cells 
were fixed and permeabilized (Fix & Perm Cell Permeabilization kit; Invit-
rogen) before staining for CD4 and IFN-, as previously described (Reed 
inflammation, yet retain sufficient protective immunity. The 
regulation of this homeostatic status quo clearly requires fur-
ther investigation.
MATERIALS AND METHODS
Subjects. This work was approved by the Ethics Committee of the Royal 
Free Hospital. Healthy young individuals under the age of 40 yr (n = 81; 
median age = 30 yr) and old individuals over 70 yr (n = 81, median age = 
79.50 yr) were recruited for the study. Exclusion criteria based on a modified 
version of the SENIEUR protocol were used to recruit old people to reduce 
confounding factors caused by associated significant comorbidity (Ligthart 
et al., 1984). All volunteers provided written informed consent, and study 
procedures were performed in accordance with the principles of the declara-
tion of Helsinki.
Skin tests. DTH responses were induced by intradermal injection of anti-
gen on non–sun-exposed skin of the medial proximal volar forearm. 0.02 ml 
candin skin test solution (n = 40 young, 34 old; Allermed Laboratories, Inc), 
0.1  ml  of  10  U/ml  tuberculin  PPD  (Evans  Vaccines  Ltd;  n  =  37  young,   
35 old), and VZV skin test antigen (gift from M. Takahashi, Osaka University, 
Osaka, Japan; n = 11 young, 15 old) were used as skin test antigens. Indura-
tion, palpability, and the change in erythema from baseline were measured 
and scored on day 3 as described previously (Orteu et al., 1998). A clinical 
score (range 0–15) based on these parameters was then assigned. The injec-
tion site was sampled by skin biopsy or skin suction blister at an allotted time 
point between 0 and 7 d after the skin test injection.
Skin biopsies. Punch biopsies (5 mm diam) from the site of antigen injection 
were obtained from 20 young volunteers and 21 old volunteers at various time 
points (24 h, day 3 and day 7) after C. albicans skin test injection. Control skin-
punch biopsies from normal noninjected forearm skin (n = 5 young, 5 old) 
were also obtained. Biopsies were frozen in optimal cutting temperature com-
pound (Bright Instrument Company Ltd). 6-µm sections were cut and left to 
dry overnight, and then fixed in ethanol and acetone and stored at 80°C.
Suction blisters. Skin suction blisters were induced by the application of a 
negative pressure of 25–40 kPa (200–300 mmHg) below atmospheric pres-
sure via a suction chamber for 2–4 h using a clinical suction pump (VP25; 
Eschmann) until a unilocular blister measuring 10–15 mm in diameter was 
formed. Suction blisters were raised over the sites of PPD injection (man-
toux reactions), C. albicans skin test injection, or normal skin 18–24 h before 
sampling to ensure maximum cell recovery. The blister fluid was microcen-
trifuged at 650 g for 4 min to pellet the cells present. The pellet was resus-
pended in complete medium (Invitrogen) containing 10% human AB serum, 
100 U/ml penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine (all 
obtained from Sigma-Aldrich).
Immunohistochemistry. Skin sections from normal and C. albicans– 
injected skin (n = 25 young, 26 old) were stained with optimal dilutions of 
purified mouse anti–human CD3 antibody (Dako), purified mouse anti– 
human CD4 antibody (BD), purified mouse anti–human CD8 antibody 
(Dako), purified mouse anti–human CD163 antibody (Acris), and anti–
TNF- FITC (BD). Rabbit anti–mouse horseradish peroxidase–conjugated 
antibody (Dako) was added to detect anti-CD3, -CD4, and -CD8. The 
staining signal for these antibodies was developed using chromagen 3- 
diaminobenzidine tetrahydrochloride. The five largest perivascular infiltrates 
in the upper and mid-dermis were photographed using a camera (model 
DXM1200F; Nikon) and Eclipse Net software version 1.16.3 for Nikon. 
The number of positive cells in these infiltrates was counted using Adobe 
Photoshop CS2 software. Biotin-labeled horse anti–mouse antibodies (Vec-
tor Laboratories) were used to detect CD163 and TNF- antibodies, respec-
tively. The staining signal was amplified with avidin–biotin complex (Vector 
Laboratories)  and  developed  using  chromogen  3-amino-9-ethylcarbazole 
(Sigma-Aldrich). The number of positive cells per millimeter was counted 
manually using computer-assisted image analysis (NIH Image 6.1; http://
rsb.info.nih.gov/nih-image).JEM VOL. 206, August 31, 2009 
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tion of TNF- by young and old peripheral blood monocytes stimulated 
with different doses of LPS. Fig. S4 shows representative suppression assay 
comparing the capacity of young and old T reg cells to suppress proliferation 
in response to C. albicans antigens in vitro. Online supplemenatl material is 
available at http://www,jem.org/cgi/content/full/jem.20090896/DC1.
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